Starting with a discovery in zebrafish in 2007, Harvard Stem Cell Institute researchers have published initial results of a Phase Ib human clinical trial of a therapeutic that has the potential to improve the success of blood stem cell transplantation. This marks the first time, just nine short years after Harvard's major commitment to stem cell biology, that investigators have carried a discovery from the lab bench to the clinic -- fulfilling the promise on which HSCI was founded.
Fuente : http://www.eurekalert.org/pub_releases/2013-10/hu-...
Fuente : http://www.eurekalert.org/pub_releases/2013-10/hu-...